NEW YORK, NY--(Marketwire - Nov 29, 2012) -  Daxor Corporation (NYSE MKT: [ DXR ]), an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend today.

The Board of Directors has approved payment of a dividend of $0.10 per share. The dividend will be paid on Thursday, December 27th to shareholders of record on Tuesday, December 11th. The Company previously paid a dividend in 2012 of $0.10 per share on August 24^th.

In 2011, the Company paid a total dividend of $0.25 per share as follows: $0.15 per share on June 16th and $0.10 per share on November 30th.

Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer which is used in conjunction with Volumex, Daxor's single use diagnostic kit. The BVA-100 provides key information that can be used to diagnose and treat various medical conditions including congestive heart failure, hypertension, anemia, blood loss during surgery, trauma, and shock (collapse of blood pressure). 

At the present time, physicians must treat these conditions by guessing whether or not they are due to volume expansions or contractions. The Blood Volume Analyzer allows precise quantitation of patients' total blood volume and red blood cell volume, which takes the guesswork out of this process. Appropriate therapies can then be employed to correct excesses or deficits in volume, leading to better outcomes for patients.

For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at [ www.Daxor.com ].